Christopher J. Sobecki
Board Member
Lexicon Pharmaceuticals, Inc. (LXRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christopher J. Sobecki
Christopher J. Sobecki is recorded as Board Member at Lexicon Pharmaceuticals, Inc. (LXRX). Earlier roles on record: Board Member at Ww International, Inc. (WW) until May 31, 2023. Ww International, Inc. reported in an 8-K filed May 15, 2023 that Christopher J. Sobecki resigned as director, effective May 31, 2023.
“On May 12, 2023, Christopher J. Sobecki notified the Secretary of WW International, Inc. (the "Company") of his resignation as a director of the Company, effective as of 11:59 p.m on May 31, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2023-05-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexicon Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Exton, Ph.D. CEO, Board Member
- Michael S. Exton CEO, Board Member
- Raymond Debbane Chairman
- Kristen L. Alexander CFO, Chief Accounting Officer
- Jeffrey L. Wade COO
- Diane E. Sullivan Board Member
- Ivan H. Cheung Board Member
- Judith L. Swain Board Member
- Philippe J. Amouyal Board Member
- Samuel L. Barker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.